img

Global Flunixin Meglumine Injection Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global Flunixin Meglumine Injection Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Flunixin Meglumine Injection Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Flunixin Meglumine Injection industry at home and abroad, estimate the overall market scale of the Flunixin Meglumine Injection industry and the market share of major countries, Flunixin Meglumine Injection industry, and study and judge the downstream market demand of Flunixin Meglumine Injection through systematic research, Analyze the competition pattern of Flunixin Meglumine Injection, so as to help solve the pain points of various stakeholders in Flunixin Meglumine Injection industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Flunixin Meglumine Injection Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Flunixin Meglumine Injection Market?
Norbrook
Zoteis
Merck Animal Health
Virbac Animal Health India Private Limited
MSD Animal Health
Bengal Remedies Limited
Wuhan Huisheng Biological Technology Co., Ltd.
Qilu Animal Health Products Co., Ltd.
Baimukang Animal Pharmaceutical Co., Ltd.
Shandong Zhongmu Veterinary Medicine Co., Ltd.
Hebei New Century Pharmaceutical Co., Ltd.
Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
Major Type of Flunixin Meglumine Injection Covered in XYZResearch report
10ml/Dose
20ml/ Dose
Application Segments Covered in XYZResearch Market
Animal muscle pain
Animal febrile disease
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Flunixin Meglumine Injection Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Flunixin Meglumine Injection Market by Value
2.2.1 Global Flunixin Meglumine Injection Revenue by Type
2.2.2 Global Flunixin Meglumine Injection Market by Value (%)
2.3 Global Flunixin Meglumine Injection Market by Production
2.3.1 Global Flunixin Meglumine Injection Production by Type
2.3.2 Global Flunixin Meglumine Injection Market by Production (%)

3. The Major Driver of Flunixin Meglumine Injection Industry
3.1 Historical & Forecast Global Flunixin Meglumine Injection Demand
3.2 Largest Application for Flunixin Meglumine Injection (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Flunixin Meglumine Injection Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Flunixin Meglumine Injection Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Flunixin Meglumine Injection Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Flunixin Meglumine Injection Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Flunixin Meglumine Injection Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Flunixin Meglumine Injection Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Flunixin Meglumine Injection Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Flunixin Meglumine Injection Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Flunixin Meglumine Injection Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Flunixin Meglumine Injection Average Price Trend
12.1 Market Price for Each Type of Flunixin Meglumine Injection in US (2018-2022)
12.2 Market Price for Each Type of Flunixin Meglumine Injection in Europe (2018-2022)
12.3 Market Price for Each Type of Flunixin Meglumine Injection in China (2018-2022)
12.4 Market Price for Each Type of Flunixin Meglumine Injection in Japan (2018-2022)
12.5 Market Price for Each Type of Flunixin Meglumine Injection in India (2018-2022)
12.6 Market Price for Each Type of Flunixin Meglumine Injection in Korea (2018-2022)
12.7 Market Price for Each Type of Flunixin Meglumine Injection in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Flunixin Meglumine Injection Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Flunixin Meglumine Injection

14. Flunixin Meglumine Injection Competitive Landscape
14.1 Norbrook
14.1.1 Norbrook Company Profiles
14.1.2 Norbrook Product Introduction
14.1.3 Norbrook Flunixin Meglumine Injection Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Zoteis
14.2.1 Zoteis Company Profiles
14.2.2 Zoteis Product Introduction
14.2.3 Zoteis Flunixin Meglumine Injection Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Merck Animal Health
14.3.1 Merck Animal Health Company Profiles
14.3.2 Merck Animal Health Product Introduction
14.3.3 Merck Animal Health Flunixin Meglumine Injection Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Virbac Animal Health India Private Limited
14.4.1 Virbac Animal Health India Private Limited Company Profiles
14.4.2 Virbac Animal Health India Private Limited Product Introduction
14.4.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 MSD Animal Health
14.5.1 MSD Animal Health Company Profiles
14.5.2 MSD Animal Health Product Introduction
14.5.3 MSD Animal Health Flunixin Meglumine Injection Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Bengal Remedies Limited
14.6.1 Bengal Remedies Limited Company Profiles
14.6.2 Bengal Remedies Limited Product Introduction
14.6.3 Bengal Remedies Limited Flunixin Meglumine Injection Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Wuhan Huisheng Biological Technology Co., Ltd.
14.7.1 Wuhan Huisheng Biological Technology Co., Ltd. Company Profiles
14.7.2 Wuhan Huisheng Biological Technology Co., Ltd. Product Introduction
14.7.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Qilu Animal Health Products Co., Ltd.
14.8.1 Qilu Animal Health Products Co., Ltd. Company Profiles
14.8.2 Qilu Animal Health Products Co., Ltd. Product Introduction
14.8.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Baimukang Animal Pharmaceutical Co., Ltd.
14.9.1 Baimukang Animal Pharmaceutical Co., Ltd. Company Profiles
14.9.2 Baimukang Animal Pharmaceutical Co., Ltd. Product Introduction
14.9.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Shandong Zhongmu Veterinary Medicine Co., Ltd.
14.10.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Profiles
14.10.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Product Introduction
14.10.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Hebei New Century Pharmaceutical Co., Ltd.
14.12 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
14.13 Shandong Lukang Pharmaceutical Co., Ltd.
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Flunixin Meglumine Injection Industry (Volume)
Figure 2. Flunixin Meglumine Injection Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Flunixin Meglumine Injection Revenue in 2022
Figure 5. US Flunixin Meglumine Injection Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Flunixin Meglumine Injection Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Flunixin Meglumine Injection Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Flunixin Meglumine Injection Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Flunixin Meglumine Injection Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Flunixin Meglumine Injection Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Flunixin Meglumine Injection Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Flunixin Meglumine Injection Revenue, by Type (Million USD) (2018-2028)
Table 4. Flunixin Meglumine Injection Production, by Type (K Unit) (2018-2028)
Table 5. Flunixin Meglumine Injection Demand (K Unit) by Application (2018-2028)
Table 6. Flunixin Meglumine Injection Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Flunixin Meglumine Injection Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Flunixin Meglumine Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Flunixin Meglumine Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Flunixin Meglumine Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Flunixin Meglumine Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Flunixin Meglumine Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Flunixin Meglumine Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Flunixin Meglumine Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Flunixin Meglumine Injection in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Flunixin Meglumine Injection in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Flunixin Meglumine Injection in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Flunixin Meglumine Injection in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Flunixin Meglumine Injection in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Flunixin Meglumine Injection in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Flunixin Meglumine Injection in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Norbrook Profiles
Table 61. Norbrook Flunixin Meglumine Injection Product Introduction
Table 62. Norbrook Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Norbrook Strategic initiatives
Table 64. Zoteis Profiles
Table 65. Zoteis Flunixin Meglumine Injection Product Introduction
Table 66. Zoteis Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Zoteis Strategic initiatives
Table 68. Merck Animal Health Profiles
Table 69. Merck Animal Health Flunixin Meglumine Injection Product Introduction
Table 70. Merck Animal Health Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Merck Animal Health Strategic initiatives
Table 72. Virbac Animal Health India Private Limited Profiles
Table 73. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Introduction
Table 74. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Virbac Animal Health India Private Limited Strategic initiatives
Table 76. MSD Animal Health Profiles
Table 77. MSD Animal Health Flunixin Meglumine Injection Product Introduction
Table 78. MSD Animal Health Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. MSD Animal Health Strategic initiatives
Table 80. Bengal Remedies Limited Profiles
Table 81. Bengal Remedies Limited Flunixin Meglumine Injection Product Introduction
Table 82. Bengal Remedies Limited Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Bengal Remedies Limited Strategic initiatives
Table 84. Wuhan Huisheng Biological Technology Co., Ltd. Profiles
Table 85. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Introduction
Table 86. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Wuhan Huisheng Biological Technology Co., Ltd. Strategic initiatives
Table 88. Qilu Animal Health Products Co., Ltd. Profiles
Table 89. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Introduction
Table 90. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Qilu Animal Health Products Co., Ltd. Strategic initiatives
Table 92. Baimukang Animal Pharmaceutical Co., Ltd. Profiles
Table 93. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Introduction
Table 94. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Baimukang Animal Pharmaceutical Co., Ltd. Strategic initiatives
Table 97. Shandong Zhongmu Veterinary Medicine Co., Ltd. Profiles
Table 98. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Introduction
Table 99. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Shandong Zhongmu Veterinary Medicine Co., Ltd. Strategic initiatives
Table 101. Hebei New Century Pharmaceutical Co., Ltd. Profiles
Table 102. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Introduction
Table 103. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Hebei New Century Pharmaceutical Co., Ltd. Strategic initiatives
Table 105. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Profiles
Table 106. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Introduction
Table 107. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Strategic initiatives
Table 109. Shandong Lukang Pharmaceutical Co., Ltd. Profiles
Table 110. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Introduction
Table 111. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. Shandong Lukang Pharmaceutical Co., Ltd. Strategic initiatives